Congresses and Meetings

This website is intended for healthcare professionals (HCPs) only. If you are an HCP, register free to access the full content.

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Roche Products Ltd. Please contact Roche Drug Safety Centre by emailing welwyn.uk_dsc@roche.com or calling +44 (0)1707 367554.

Congress Highlights

06.10.2021

EHA and ICML 2021

Learn more about the key haematology data highlights presented at the virtual EHA 2021 and ICML 2021 congresses, and how they could impact UK clinical practice.
More
03.09.2021

Annual US Oncology Meeting 2021 (#ASCO2021)

Learn more about the key breast cancer data highlights presented at the 2021 Annual US Oncology Meeting.
More
30.09.2021

ASH 2020

Learn more about the key haematology data highlights presented at the virtual edition of the ASH 2020 congress and how they could impact UK clinical practice.
More
30.09.2021

ABN 2020

Take a look at the Roche data presented at virtual ABN 2020.
More

Prescribing Information OCREVUS®▼(ocrelizumab) Great Britain
Prescribing Information OCREVUS®▼(ocrelizumab) Northern Ireland

Adverse event reporting and additional monitoring

Roche Organised Meetings & Sponsored Symposia

M-GB-00004235
Date of preparation: September 2021

Welcome to Roche Resources

Roche Resources is intended for UK Healthcare Professionals only. By entering this site you are confirming that you are a UK Healthcare professional.

I am a healthcare professional I am a member of the public